Page last updated: 2024-09-05

4-n-butylresorcinol and arbutin

4-n-butylresorcinol has been researched along with arbutin in 4 studies

Compound Research Comparison

Studies (4-n-butylresorcinol)	Trials (4-n-butylresorcinol)	Recent Studies (post-2010) (4-n-butylresorcinol)	Studies (arbutin)	Trials (arbutin)	Recent Studies (post-2010) (arbutin)
23	7	19	542	17	276

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T	1
Haudecoeur, R; Pérès, B; Roulier, B	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Ahlheit, S; Batzer, J; Gerwat, W; Kolbe, L; Mann, T; Scherner, C; Stäb, F; Wenck, H	1

Reviews

2 review(s) available for 4-n-butylresorcinol and arbutin

Article	Year
Inhibitors of Melanogenesis: An Updated Review. Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17 Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin	2018
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations. Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22 Topics: Agaricales; Amino Acid Sequence; Biological Factors; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Pigmentation; Protein Structure, Secondary; Skin Lightening Preparations	2020

Article

Year

Inhibitors of Melanogenesis: An Updated Review.

Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin

2018

Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.

Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22

Topics: Agaricales; Amino Acid Sequence; Biological Factors; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Pigmentation; Protein Structure, Secondary; Skin Lightening Preparations

2020

Trials

1 trial(s) available for 4-n-butylresorcinol and arbutin

Article	Year
4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27 Suppl 1 Topics: Administration, Topical; Aged; Arbutin; Female; Humans; Hydroquinones; Hyperpigmentation; Melanins; Middle Aged; Monophenol Monooxygenase; Pyrones; Resorcinols; Single-Blind Method; Skin; Skin Lightening Preparations; Tissue Culture Techniques; Treatment Outcome	2013

Article

Year

4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27 Suppl 1

Topics: Administration, Topical; Aged; Arbutin; Female; Humans; Hydroquinones; Hyperpigmentation; Melanins; Middle Aged; Monophenol Monooxygenase; Pyrones; Resorcinols; Single-Blind Method; Skin; Skin Lightening Preparations; Tissue Culture Techniques; Treatment Outcome

2013

Other Studies

1 other study(ies) available for 4-n-butylresorcinol and arbutin

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023